171 related articles for article (PubMed ID: 36920956)
21. MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya.
Mantell J; Franks J; Zerbe A; Lamb MR; Reed DM; Omollo D; Lahuerta M; Naitore D; El-Sadr WM; Agot K
BMJ Open; 2022 Nov; 12(11):e064037. PubMed ID: 36332953
[TBL] [Abstract][Full Text] [Related]
22. Qualitative Examination of the Impact of the COVID-19 Pandemic on Access and Adherence to Pre-exposure Prophylaxis (PrEP) Among Sexual and Gender Minorities.
Yeager S; Serrano VB; Paltin D; Fisher A; Karris M; Aarons GA; Rangel A; Flynn R; Bolan R; Moore DJ; Montoya JL
AIDS Educ Prev; 2023 Aug; 35(4):255-267. PubMed ID: 37535324
[TBL] [Abstract][Full Text] [Related]
23. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
[TBL] [Abstract][Full Text] [Related]
24. Linking emergency department patients at risk for human immunodeficiency virus to pre-exposure prophylaxis.
Mahal J; Deccy S; Seu R
Am J Emerg Med; 2022 Apr; 54():87-90. PubMed ID: 35151016
[TBL] [Abstract][Full Text] [Related]
25. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
[TBL] [Abstract][Full Text] [Related]
26. Exploring nurse-led HIV Pre-Exposure Prophylaxis in a community health care clinic.
Selfridge M; Card KG; Lundgren K; Barnett T; Guarasci K; Drost A; Gray-Schleihauf C; Milne R; Degenhardt J; Stark A; Hull M; Fraser C; Lachowsky NJ
Public Health Nurs; 2020 Nov; 37(6):871-879. PubMed ID: 32996157
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the impact of human immunodeficiency virus pre-exposure prophylaxis on new human immunodeficiency virus diagnoses during the COVID-19 pandemic.
Keane A; Regan SO; Quinn L; Murphy D; Kelly BO; Lynam A; Lyons F; Devitt E
Int J STD AIDS; 2022 Jan; 33(1):99-102. PubMed ID: 34852685
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
Ten Brink DC; Martin-Hughes R; Minnery ME; Osborne AJ; Schmidt HA; Dalal S; Green KE; Ramaurtarsing R; Wilson DP; Kelly SL
PLoS One; 2022; 17(5):e0268240. PubMed ID: 35617169
[TBL] [Abstract][Full Text] [Related]
29. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
[TBL] [Abstract][Full Text] [Related]
30. "What other choices might I have made?": Sexual Minority Men, the PrEP Cascade and the Shifting Subjective Dimensions of HIV Risk.
Gaspar M; Wells A; Hull M; Tan DHS; Lachowsky N; Grace D
Qual Health Res; 2022 Jul; 32(8-9):1315-1327. PubMed ID: 35616240
[TBL] [Abstract][Full Text] [Related]
31. Examining patient characteristics and HIV-related risks among women with syphilis as indicators for pre-exposure prophylaxis in a nurse-led program (PrEP-RN).
Orser L; O'Byrne P
Int J STD AIDS; 2021 Jan; 32(1):45-51. PubMed ID: 33121363
[TBL] [Abstract][Full Text] [Related]
32. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
[TBL] [Abstract][Full Text] [Related]
33. Modeling the potential impact of pre-exposure prophylaxis for HIV among men who have sex with men in Cameroon.
Lyons CE; Stokes-Cawley OJ; Simkin A; Bowring AL; Mfochive Njindam I; Njoya O; Bissek AZ; Tamoufe U; Georges S; Kakanou FZ; Turpin G; Levitt D; Billong SC; Mishra S; Baral S
BMC Infect Dis; 2022 Sep; 22(1):751. PubMed ID: 36163000
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW).
Dharan NJ; Jin F; Vaccher S; Bavinton B; Yeung B; Guy R; Carr A; Zablotska I; Amin J; Read P; Templeton DJ; Ooi C; Martin SJ; Ryder N; Smith DE; McNulty A; Brown K; Price K; Holden J; Grulich AE;
Clin Infect Dis; 2023 Feb; 76(3):e622-e628. PubMed ID: 35982613
[TBL] [Abstract][Full Text] [Related]
35. PrEP Use in Times of COVID-19 in the Netherlands: Men Who Have Sex With Men (MSM) on PrEP Test Less for HIV and Renal Functioning During a COVID-19 Related Lockdown.
Krist LC; Zimmermann HML; van Dijk M; Stutterheim SE; Jonas KJ
AIDS Behav; 2022 Nov; 26(11):3656-3666. PubMed ID: 35578141
[TBL] [Abstract][Full Text] [Related]
36. Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada.
Greenwald ZR; Maheu-Giroux M; Szabo J; Robin JAB; Boissonnault M; Nguyen VK; Thomas R
BMJ Open; 2019 Jun; 9(6):e028768. PubMed ID: 31248931
[TBL] [Abstract][Full Text] [Related]
37. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
[TBL] [Abstract][Full Text] [Related]
38. HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers.
Kutscha F; Gaskins M; Sammons M; Nast A; Werner RN
Front Public Health; 2020; 8():298. PubMed ID: 32760688
[No Abstract] [Full Text] [Related]
39. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
40. Addressing the Need for a Preexposure Prophylaxis Monitoring and Evaluation Implementation Guide: Experience From Zambia.
Lavoie MC; Blanco N; Mwango LK; Nichols BE; Whittington A; Lindsay B; Adebayo O; Mujansi M; Tembo K; Hachaambwa L; Mumba D; Musonda B; Claassen CW
Glob Health Sci Pract; 2023 Apr; 11(2):. PubMed ID: 37116937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
